Zoetis Boosts Dividend, Signaling Strength in Animal Health Science
PARSIPPANY, N.J. — December 11, 2025 — Zoetis Inc., the world’s leading animal health company, announced that its Board...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PARSIPPANY, N.J. — December 11, 2025 — Zoetis Inc., the world’s leading animal health company, announced that its Board...
Houston, Texas – September 23, 2025 — Eli Lilly and Company (NYSE: LLY) will invest $6.5 billion to build...
September 16, 2025 — Morpeth, United Kingdom Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO),...
